The adhesion of human platelets to the human arterial subendothelium was investigated using everted postmortem renal arteries after the first bifurcation and reconstituted blood containing 51Cr-labelled, aspirin-treated platelets in a perfusion chamber according to Baumgartner. The accumulation of 51Cr on the arterial segment was a reliable reflection of the number of platelets that adhered. The dependence of platelet adhesion on platelet number, perfusion time, haematocrit and perfusion rate were found to be similar to what was observed with rabbit aorta previously, notwithstanding the essentially different nature of the human subendothelium, with its layers of smooth muscle cells above the internal elastic lamina. The system was used to study the role of factor VIII-von Willebrand factor (VIII-VWF). VIII-VWF was found to be the only plasma factor enhancing adhesion of platelets to the vessel wall. No suggestion of an inhibitory substance in plasma was found. Double perfusion experiments indicated that VIII-VWF binding to subendothelium supported subsequent platelet adhesion. A good correlation was found between the amount of VIII-VWF bound and platelet adhesion. Comparison of binding of albumin, fibrinogen, 7-globulin and VIII-VWF showed that VIII-VWF bound less. This suggests that VIII-VWF does penetrate less easily in the subendothelium, which is in agreement with immunofluorescence studies of tissues. Studies with washed platelets not treated with aspirin showed parallelism between accumulation of VIII-VWF and platelet deposition in thrombi. These data may be explained by assuming a non-easily exchangeable pool of VIII-VWF on the platelet surface and increased binding of VIII-VWF to platelets in thrombi.

Keywords:
Platelet adhesion, Subendothelium, Factor VIII, Von Willebrand factor, 51Cr-labelled, aspirin-treated platelets
This content is only available via PDF.
© 1979 S. Karger AG, Basel
1979
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.